Why the study?
Does revascularization improve survival compared to medical therapy in patients with ischemic cardiomyopathy based on the presence of hibernating myocardium?
Does revascularization improve survival compared to medical therapy in patients with ischemic cardiomyopathy based on the presence of hibernating myocardium?
In patients with ischemic cardiomyopathy, the presence of hibernating myocardium, rather than ischemia, identifies those who may gain a survival benefit from revascularization.
Answers are grounded in this paper and cite their sources.
Viability imaging may inform revascularization decisions in ischemic cardiomyopathy; leaves open need for randomized confirmation.
Among patients with ischemic cardiomyopathy, hibernating, but not ischemic, myocardium identifies which patients may accrue a survival benefit with revascularization versus medical therapy.
No takes yet. Share an insight, caveat, or question.
Ling et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: